NCT00014742 2015-03-25
Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease
FDA Office of Orphan Products Development
Phase 3 Completed
FDA Office of Orphan Products Development
Philips Healthcare
Office of Rare Diseases (ORD)